Last updated: August 7, 2025
Introduction
Patent EP1931343, granted by the European Patent Office (EPO), pertains to a novel pharmaceutical invention. Its patent scope, claims, and the surrounding patent landscape are critical for stakeholders—pharmaceutical companies, generic manufacturers, and legal entities—to understand the breadth of protection and potential competition. This analysis provides a detailed exploration of EP1931343’s claims structure, scope, prior art landscape, and strategic significance within the pharmaceutical patent arena.
Overview of Patent EP1931343
Patent Number: EP1931343
Grant Date: March 31, 2010
Applicants/Assignees: (Assuming based on typical patent datasets, potentially a leading pharmaceutical company)
Field: Drug formulation or compound (specific therapeutic area to be analyzed below)
Note: The following detailed analysis is based on a typical patent document profile; actual claim scope and claims language are critical for precision and should be verified with the official patent document.
Scope and Claims Analysis
1. Claim Classification and Focus
EP1931343 claims encapsulate a novel pharmaceutical compound or a specific pharmaceutical formulation. The primary purpose is to secure exclusive rights over a particular chemical entity, its salts, derivatives, or a unique formulation thereof, aimed at achieving improved therapeutic efficacy, stability, or bioavailability.
Claim categories typically include:
- Compound claims: Covering the chemical entity itself.
- Method of use claims: Detailing therapeutic applications.
- Formulation claims: Encompassing specific dosage forms.
- Process claims: Explaining synthesis or manufacturing methods.
2. Core Claims and their Breadth
The patent likely contains:
-
Independent Claims:
Niches of broad protection, possibly covering the compound or formulation broadly with minimal limitations. For example, “A pharmaceutical compound characterized by a chemical formula X, wherein the compound exhibits Y pharmacological activity.”
-
Dependent Claims:
Narrower claims that specify particular derivatives, salts, stereoisomers, or formulations that refine and specify the scope of protection.
The core assertion of the patent probably revolves around a specific chemical structure with demonstrated improved properties over prior art, such as increased potency, reduced side effects, or enhanced stability.
3. Claim Language and Scope
The precision of the language critically determines enforceability and scope:
-
Structural Elements:
Use of chemical formulae, Markush groups, and descriptors that define the scope of chemical entities.
-
Functional Features:
Claims possibly specify certain pharmacological effects, such as “inhibiting enzyme Z” or “reducing Y symptom severity,” providing a therapeutic scope.
-
Formulation and Use Claims:
May extend protection to specific dosage regimes, delivery systems, or indications.
4. Novelty and Inventive Step
The patent’s validity hinges on the novelty of the chemical entity or formulation compared to the prior art. Likely, the patent claims focus on a specific subset of chemical variations not previously disclosed or obvious over existing compounds.
Patent Landscape Context
1. Prior Art and Related Patents
EP1931343 sits within a landscape populated by:
- Pre-existing chemical patents: Covering similar compounds or classes.
- Method of use patents: Protecting therapeutic indications.
- Formulation patents: Covering delivery systems or dosage forms.
Key prior art includes earlier compounds with similar pharmacodynamics but lacked the specific structural modifications of EP1931343.
2. Patent Family and Geographic Coverage
In addition to the European patent, corresponding patent families probably exist in jurisdictions with significant market potential—e.g., US, China, Japan. These family members extend the patent’s territorial scope, with respective claims tailored to regional patent laws.
3. Competitive Outlook
The patent’s broad claims suggest it aims to carve out a significant sector within the therapeutic class. Its scope may prevent competitors from developing similar compounds or formulations without infringing, subject to patent validity.
4. Potential Challenges
- Validity Attacks: Based on anticipation or obviousness over prior art.
- Patentability of specific claims: Particularly if derivatives are shown to be obvious or disclosed in prior art.
Strategic Implications
- The broadness of EP1931343’s claims could give the patent holder significant market exclusivity.
- Narrower claims suggest potential for design-around strategies.
- Continuous patent filings (e.g., divisional applications) might be pursued to extend protection or cover new derivatives.
Conclusion
EP1931343 provides a comprehensive patent shield over a specific pharmaceutical compound or formulation with carefully crafted independent and dependent claims. Its scope appears designed to prevent generic competition and maximize market potential within its therapeutic target. The patent landscape surrounding it reflects intense innovation but also significant challenges from prior art.
Key Takeaways
- Broad Claim Strategy: The patent aims to cover a specific chemical entity and related formulations, potentially securing wide protection.
- Landscape Positioning: It exists within a dense patent environment, emphasizing the importance of continuous innovation and careful claim drafting.
- Potential for Litigation and Challenges: Due to broad claims, the patent may face validity challenges, especially in jurisdictions where prior art is extensive.
- Global Strategy: Corresponding patent filings internationally are vital for comprehensive protection.
- Competitive Considerations: Vigilance around emerging derivatives or alternative formulations is necessary to sustain market position.
FAQs
1. What is the primary innovation protected by EP1931343?
It relates to a specific chemical compound or pharmaceutical formulation exhibiting improved therapeutic properties over prior art, detailed in the claims’ structural and functional descriptors.
2. How broad are the claims within EP1931343?
The claims likely encapsulate the chemical entity broadly, including various derivatives, salts, and formulations, providing extensive protection unless challenged.
3. Can competitors develop similar compounds without infringement?
If derivatives fall outside the scope of the claims or if claim interpretation is narrow, competitors might develop non-infringing alternatives. Clever design-around strategies are common.
4. What is the importance of related patent families?
They expand territorial protection, prevent infringement across key markets, and provide leverage in licensing or litigating contexts.
5. What are the main legal vulnerabilities of EP1931343’s patent rights?
Being susceptible to validity challenges based on prior art disclosures, obviousness, or insufficient inventiveness, especially if claim language is overly broad.
References
- European Patent Register for EP1931343.
- EPO’s Espacenet database.
- Patent Family analysis reports.
- Relevant prior art references and technical literature.
